Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0778 CHF | +22.71% | +27.54% | +89.76% |
05-01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+89.76% | 4.73M | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-13.27% | 32.25B | |
+54.69% | 25.14B | |
-16.50% | 15.39B | |
-9.05% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Spexis Strikes Clinical Trial Partnership to Develop Lung Infection Drug ColiFin